ArticleClinical and experimental medicine2026
Neutrophil extracellular Trap-related genes in NAFLD: Biomarkers and therapeutic targets.
Article in Clinical and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The etiology of non-alcoholic fatty liver disease (NAFLD) is complex. This study seeks to clarify the importance of neutrophil extracellular traps (NETs) -related genes in NAFLD. Integrated NAFLD datasets were obtained from GEO. NETs-related differentially expressed genes (NETsRDEGs) were identified and analyzed for functional enrichment. A diagnostic model was developed using logistic regression and Least Absolute Shrinkage and Selection Operator regression (LASSO) methods, followed by validation through receiver operating characteristic curve analysis. Immune cells infiltration assessments, regulatory network analyses, and protein domain predictions were conducted to illuminate the molecular mechanisms underlying NAFLD. We identified 22 NETsRDEGs and constructed an 8-gene diagnostic model (TLR7, LDLR, CCL2, S100A8, PADI4, F3, CD274, NFIL3) that effectively distinguished NAFLD from controls (area under the curve [AUC] = 0.920). Enrichment analyses revealed significant involvement of PI3K-AKT signaling and negative regulation of NOTCH4 signaling. Immune infiltration analysis demonstrated altered abundances of activated CD8 + T cells and Type 2 T helper in NAFLD. Several compounds, including resveratrol and curcumin, were identified as potential therapeutics. Our findings underscore the significance of NETs in NAFLD pathogenesis, involving inflammatory pathways and immune dysregulation. The identified NETsRDEGs and diagnostic model offer promising biomarkers and therapeutic avenues for NAFLD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.